[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved the OTC switch for a migraine device. This approval is for Cefaly Dual (Cefaly Technology). The FDA approved

[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new fast-acting medication to treat migraines. This new medication is the first fast-acting, orally disintegrating tablet of

[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new medication to treat migraines. This new approval is for Ubrelvy (ubrogepant). The FDA approved it to

[ad_1] (RxWiki News) A new migraine medication is hitting the market. The US Food and Drug Administration (FDA) has approved Reyvow (lasmiditan) to treat migraines. Migraines are estimated to affect

[ad_1] (RxWiki News) A new migraine medication is hitting the market. The US Food and Drug Administration (FDA) has approved Reyvow (lasmiditan) to treat migraines. Migraines are estimated to affect

[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved an injection to treat episodic cluster headaches in adults. This new drug is called Emgality (galcanezumab-gnlm). It’s available

[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved two new medications to prevent migraines in adults. These two new approvals are found under the names Ajovy

[ad_1] (RxWiki News) June is National Migraine and Headache Awareness Month. That means it’s the perfect time to review some tips for alleviating migraine and headache pain. Headaches are among

[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new medication to prevent migraines. It’s called Aimovig (erenumab-aooe). The FDA approved this treatment, available as a